Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Amanda Izeli Portilho"'
Autor:
Amanda Izeli Portilho, Valéria Oliveira Silva, Hernan Hermes Monteiro Da Costa, Rosemeire Yamashiro, Isabela Penteriche de Oliveira, Ivana Barros de Campos, Carlos Roberto Prudencio, Elaine Monteiro Matsuda, Luís Fernando de Macedo Brígido, Elizabeth De Gaspari
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Humoral response to SARS-CoV-2 has been studied, predominantly the classical IgG and its subclasses. Although IgE antibodies are typically specific to allergens or parasites, a few reports describe their production in response to SARS-CoV-2
Externí odkaz:
https://doaj.org/article/fe4c71dd31d6410db6964665bf41df7a
Autor:
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, Carlos Roberto Prudencio, Elizabeth De Gaspari
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTCOVID-19, caused by SARS-CoV-2, and meningococcal disease, caused by Neisseria meningitidis, are relevant infectious diseases, preventable through vaccination. Outer membrane vesicles (OMVs), released from Gram-negative bacteria, such as N. m
Externí odkaz:
https://doaj.org/article/c335288dc24e4c61a5bf0c2e2d224e4e
Publikováno v:
Exploration of Immunology, Vol 3, Iss 4, Pp 276-285 (2023)
The emergence and re-emergence of pathogens is a public-health concern, which has become more evident after the coronavirus disease 2019 (COVID-19) pandemic and the monkeypox outbreaks in early 2022. Given that vaccines are the more effective and aff
Externí odkaz:
https://doaj.org/article/eb8097b6cfd84ae888434f8aadeca62f
Autor:
Victor Araujo Correa, Thais Sousa Rodrigues, Amanda Izeli Portilho, Gabriela Trzewikoswki de Lima, Elizabeth De Gaspari
Publikováno v:
Biomedical Journal, Vol 44, Iss 4, Pp 433-438 (2021)
Antibody avidity is an important parameter to evaluate immune response, being useful to evaluate vaccine responses and helping to distinguish acute and latent infection. The antibody avidity can be measured by different methods, yet the most common i
Externí odkaz:
https://doaj.org/article/90bee62c183e444490641048e4f087bc
Publikováno v:
Pathogens, Vol 12, Iss 1, p 20 (2022)
Since late 2019 and early 2020, with the emergence of the COVID-19 pandemic, scientists are rushing to develop treatment and prevention methods to combat SARS-CoV-2. Among these are vaccines. In view of this, the use of animals as experimental models
Externí odkaz:
https://doaj.org/article/e06d47f4f810436e9dd1561be23b2bec
Publikováno v:
Diseases, Vol 10, Iss 3, p 46 (2022)
The meningococcal disease is a global health threat, but is preventable through vaccination. Adjuvants improve meningococcal vaccines and are able to trigger different aspects of the immune response. The present work evaluated the immune response of
Externí odkaz:
https://doaj.org/article/6d0d5f46fcb74b1f8b7077aee672f6b2
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 6, p 1503 (2022)
The Enzyme-Linked Immunosorbent Assay is a versatile technique, which can be used for several applications. It has enormously contributed to the study of infectious diseases. This review highlights how this methodology supported the science conducted
Externí odkaz:
https://doaj.org/article/7b18e53e761e46a39210fb2f11d31df4
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 8 (2020)
Background: Neisseria meningitidis is the main cause of bacterial meningitis in Brazil, where the main serogroups isolated are B and C; however, the serogroup W has recently emerged. LPS and type IV pili are important virulence factors that increase
Externí odkaz:
https://doaj.org/article/d6dc3682c9c446c1bc9b53bc03320812
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 7 (2019)
Background: Immunization against Neisseria meningitidis is important for public health. Vaccines composed of cross-reactivity antigens avoid strain-specific responses, ensuring more comprehensive protection. Methods: The cross-reactivity between thre
Externí odkaz:
https://doaj.org/article/9b5206e3fcd74737813fdece2d1dc9ae